0001209191-23-030918.txt : 20230519 0001209191-23-030918.hdr.sgml : 20230519 20230519114142 ACCESSION NUMBER: 0001209191-23-030918 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230518 FILED AS OF DATE: 20230519 DATE AS OF CHANGE: 20230519 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andriole Michael T. CENTRAL INDEX KEY: 0001698751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 23938815 MAIL ADDRESS: STREET 1: C/O ENDOCYTE, INC. STREET 2: 3000 KENT AVENUE, SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-18 0 0001117480 CHIMERIX INC CMRX 0001698751 Andriole Michael T. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 0 1 0 0 Chief Business Officer and CFO 0 Common Stock 2023-05-18 4 P 0 51700 1.1441 A 357015 D The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.135 to $1.15, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price. Includes 10,416 shares acquired under the Issuer's Employee Stock Purchase Plan on March 10, 2023. The 357,015 shares includes, 32,175 restricted stock unit awards ("RSUs") that were granted on January 17, 2023, of which 8,043 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 8,043 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 8,043 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 8,046 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant. /s/ Michael Alrutz, Attorney-in-Fact 2023-05-19